Evidence map›Paper›PMID 39838465›Full record

ArticleMicrobial cell factories2025

Development of a Komagataella phaffii cell factory for sustainable production of ( +)-valencene.

Jintao Cheng, Jiali Chen, Dingfeng Chen, Baoxian Li, Chaozhi Wei, Tao Liu, Xiao Wang, Zhengshun Wen, Yuanxiang Jin, Chenfan Sun and 1 more

Abstract read
In one paragraph

Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jintao ChengXianghu Laboratory, Hangzhou, 310027, China.
Jiali ChenXianghu Laboratory, Hangzhou, 310027, China.
Dingfeng ChenXianghu Laboratory, Hangzhou, 310027, China.
Baoxian LiXianghu Laboratory, Hangzhou, 310027, China.
Chaozhi WeiXianghu Laboratory, Hangzhou, 310027, China.
Tao LiuXianghu Laboratory, Hangzhou, 310027, China.
Xiao WangXianghu Laboratory, Hangzhou, 310027, China.
Zhengshun WenXianghu Laboratory, Hangzhou, 310027, China.
Yuanxiang JinXianghu Laboratory, Hangzhou, 310027, China.
Chenfan SunDepartment of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China. fchsun@cdc.zj.cn.
Guiling YangXianghu Laboratory, Hangzhou, 310027, China. guilingchina2008@163.com.

Funding

the major science and technology project of Zhejiang Province 2024SSYS0103the Start-up funds of Xianghu Laboratory 2023C4S02002
6 · The paper itself

Abstract

backgroundSesquiterpene ( +)-valencene is a characteristic aroma component from sweet orange fruit, which has a variety of biological activities and is widely used in industrial manufacturing of food, beverage and cosmetics industries. However, at present, the content in plant sources is low, and its yield and quality would be influenced by weather and land, which limit the supply of ( +)-valencene. The rapid development of synthetic biology has accelerated the construction of microbial cell factories and provided an effective alternative method for the production of natural products.

resultsIn this study, we first introduced the ( +)-valencene synthase into Komagataella phaffii by CRISPR/Cas9 system, and successfully constructed a ( +)-valencene producer with the initial yield of 2.1 mg/L. Subsequently, the ( +)-valencene yield was increased to 8.2 mg/L by fusing farnesyl pyrophosphate synthase with ( +)-valencene synthase using the selected ligation linker. High expression of key genes IDI1, tHMG1, ERG12 and ERG19 enhanced metabolic flux of MVA pathway, and the yield of ( +)-valencene was further increased by 27%. Besides, in-situ deletion of the promoter of ERG9 increased the yield of ( +)-valencene to 48.1 mg/L. Finally, we optimized the copy number of farnesyl pyrophosphate synthase and ( +)-valencene synthase fusion protein, and when the copy number reached three, the yield of ( +)-valencene achieved 173.6 mg/L in shake flask level, which was 82-fold higher than that of the starting strain CaVAL1.

conclusionsThe results obtained here suggest that K. phaffii has the potential to efficiently synthesize other terpenoids.

Indexed as

SesquiterpenesCRISPR-Cas SystemsMetabolic EngineeringSaccharomycetalesSesquiterpenesvalenceneCell factoryCRISPR/Cas9Komagataella phaffiiSynthetic biology( +)-Valencene

Identifiers

PMID39838465
PMCPMC11752624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.